Mackenzie Institute Keynote Speaker --- Sir Harpal Kumar Cancer Early Diagnosis - The role of Science and Business in Addressing a Critical Health Need
The Mackenzie Institute for Early Diagnosis are privileged to announce the above Keynote Speaker event on 24th May, with a Keynote Lecture delivered by Sir Harpal Kumar in the Booth Lecture Theatre, at the Medical School building in St Andrews.
Sir Harpal is the President of GRAIL Europe and leads GRAIL's biopharma business globally. Prior to GRAIL, he was Senior Vice President and Head of Innovation EMEA at Johnson & Johnson. Before joining J&J, Sir Harpal spent more than 15 years with Cancer Research UK and served as the organisation's Chief Executive Officer from April 2007 until June 2018. Prior to this, he was Chief Executive of Cancer Research Technology (a subsidiary of CRUK). Sir Harpal's will be focussing his lecture on ‘Cancer Early Diagnosis – The role of Science and Business in Addressing a Critical Health Need.'
This is an exceptional opportunity and all are welcome to attend.